AlphaLISA SureFire Biotin-Free Human and Mouse Phospho-STAT3 (Tyr705) Detection Kit, 10,000 Assay Points

Phospho-AlphaLISA SureFire Biotin Free assay principle

The Phospho-AlphaLISA SureFire Biotin Free assay measures a protein target when phosphorylated at a specific residue.

The assay uses two antibodies which recognize the phospho epitope and a distal epitope on the targeted protein. AlphaLISA assays require two bead types: Acceptor and Donor beads. Acceptor beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor beads are coated with a proprietary CaptSure 3 agent to capture one of the detection antibodies, which is labeled with CaptSure 3 tag. In the presence of phosphorylated protein, the two antibodies bring the Donor and Acceptor beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor bead, allowing the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of phosphoprotein present in the sample.

Phospho-AlphaLISA SureFire Biotin Free two-plate assay protocol

The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well Optiplate™ plate before the addition of Phospho-AlphaLISA SureFire Biotin Free detection reagents. This protocol permits the cells viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.

Phospho-AlphaLISA SureFire Biotin Free one-plate assay protocol

Detection of Phosphorylated target protein with AlphaLISA SureFire Biotin Free reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining robust AlphaLISA SureFire quality.

Activation of Phospho STAT3 (Tyr705) levels in IFNα and IFNγ treated cells

THP-1 cells were seeded in a 96-well plate (50,000 cells/well) in complete RPMI 1640 medium containing 100 nM of PMA for 24 hours at 37°C, 5% CO₂. The THP-1 derived macrophages were starved for 2 hours and then treated with increasing concentrations of IFNα or IFNγ for 20 minutes.

After treatment, the cells were lysed with 50 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). STAT3 Phospho (Tyr705) and Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 10,000 cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, IFNα and IFNγ triggered a dose-dependent increase in the levels of Phospho STAT3 (Tyr705) while Total STAT3 levels remained unchanged.

Activation of Phospho STAT3 (Tyr705) levels in IL-6 treated cells

THP-1 cells were seeded in a 96-well plate (50,000 cells/well) in complete RPMI 1640 medium containing 100 nM of PMA for 24 hours at 37°C, 5% CO₂. The THP-1 derived macrophages were starved for 2 hours and then treated with increasing concentrations of IL-6 for 20 minutes.

After treatment, the cells were lysed with 50 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). STAT3 Phospho (Tyr705) and Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step,10 µL of cell lysate (approximately 10,000 cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, IL-6 triggered a dose-dependent increase in the levels of Phospho (Tyr705) while Total STAT3 levels remained unchanged.